Expected earnings - Fate Therapeutics Inc.
Source: US Earnings Reports
Fate Therapeutics Inc. (FATE) is expected to report $-0.35 for Q2 2025
Fate Therapeutics Inc.
NASDAQ: FATE
FATE Trading
-7.32% G/L:
$1.14 Last:
552,970 Volume:
$1.19 Open:
FATE Latest News
April 02, 2026 04:05:00 pm
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2026 11:30:00 am
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven't Noticed
March 04, 2026 04:05:00 pm
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
FATE Stock Data
$128,041,041
108,996,378
1.54%
45
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
